Optical measurements of bone composition

• US 20020002336A1
• Filed: 01/19/2001
• Published: 01/03/2002
• Est. Priority Date: 01/21/2000
• Status: Abandoned Application

• Current Assignee: Rocky Mountain Biosystems, Inc., Spectra Systems Corporation
• Original Assignee: Rocky Mountain Biosystems, Inc.
• Inventors: Marchitto, Kevin S., Flock, Stephen T.
• Application Number:
  US09/765,989
• Publication Number:
  US 20020002336A1
• Time in Patent Office: Days
• US Class Current: 600/473
• CPC Class Codes: A61B 5/0059 using light, e.g. diagnosis by transillumination, diascopy, fluorescence A61B5/0093, A61B5/1455, A61B5/02416 and A61B5/0261 take precedence
• CPC Class Codes: A61B 5/4504 Bones A61B5/4547 takes precedence
• CPC Class Codes: A61B 5/4509 Bone density determination
• CPC Class Codes: G01N 2021/656 Raman microprobe
• CPC Class Codes: G01N 21/65 Raman scattering

Abstract

The present invention provides an non-invasive and inexpensive method and/or device for detecting a disease in a bone or other tissues using an optical fiber based Raman spectrometer by detecting biochemical changes in the bone or the other tissues.

Claims

1. A method for detecting a bone disease in a test subject, comprising the steps of:

transmitting radiant energy to surface of skin overlaying a bone in the test subject;

detecting radiant energy reflected from said skin surface to obtain Raman spectra, wherein the Raman spectra from the skin surface reflect the spectral information on the bone, wherein said spectral information on the bone reflects biochemical compositions of said bone; and

comparing the biochemical compositions of the test bone with those of a normal bone, wherein if the biochemical compositions of the test bone differ from those of the normal bone, the test subject might have a diseased bone.

2. The method of claim 1, wherein the radiant energy is transmitted through a fiber-optic based reflectance probe.

3. The method of claim 1, wherein the radiant energy reflected from the skin surface is collected by a fiber optic.

4. The method of claim 1, wherein said radiant energy is near-infrared light.

5. The method of claim 4, wherein said near-infrared light has a wavelength range of from about 600 nm to about 1500 nm.

6. The method of claim 1, wherein said reflected radiant energy is filtered through a long-pass filter, a band-pass filter or a polarization filter.

7. The method of claim 1, wherein said bone disease is selected from the group consisting of osteomalacia, osteoporosis, a bone cancer, and a bone infection.

8. A device for detecting a bone disease, comprising:

a source for producing radiant energy;

an applicator for transmitting radiant energy;

a means for detecting reflected radiant energy; and

a Raman spectrometer.

9. The device of claim 8, wherein said applicator for transmitting radiant energy is a fiber-optic based reflectance probe.

10. The device of claim 8, wherein said radiant energy is near-infrared light.

11. A method for detecting a disease in a test subject, comprising the steps of:

transmitting radiant energy to surface of skin overlaying a tissue of interest in the test subject;

detecting radiant energy reflected from said skin surface to obtain Raman spectra, wherein the Raman spectra from the skin surface reflect the spectral information on the tissue, wherein said spectral information on the tissue reflects biochemical compositions of said tissue;

comparing the biochemical compositions of the test tissue with those of a normal tissue, wherein if the biochemical compositions of the test tissue differ from those of the normal tissue, the test subject might have a disease.

12. The method of claim 11, wherein said disease is a cancer or an infection.